- call +1-201-465-4211
- email sales@mrinsights.biz
Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body.
Scope of the Report:
This report studies the CIS Insulin market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the CIS Insulin market by product type and applications/end industries.
Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government.
The global CIS Insulin market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of CIS Insulin.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Eli Lilly
Novo Nordisk
Takeda Pharmaceuticals
Sanofi Aventis
Nanjing Xinbai Pharmaceutical
Oramed Pharmaceuticals
Merck
Boehringer Ingelheim
Biocon
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Long-Acting Analog
Rapid Acting Analog
Premixed Analog
Intermediate Insulin
Short Acting Insulin
Premixed Insulin
Market Segment by Applications, can be divided into
Type I and Other Diabetes
Type II Diabetes
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 CIS Insulin Market Overview
1.1 Product Overview and Scope of CIS Insulin
1.2 Classification of CIS Insulin by Types
1.2.1 Global CIS Insulin Revenue Comparison by Types (2017-2023)
1.2.2 Global CIS Insulin Revenue Market Share by Types in 2017
1.2.3 Long-Acting Analog
1.2.4 Rapid Acting Analog
1.2.5 Premixed Analog
1.2.6 Intermediate Insulin
1.2.7 Short Acting Insulin
1.2.8 Premixed Insulin
1.3 Global CIS Insulin Market by Application
1.3.1 Global CIS Insulin Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Type I and Other Diabetes
1.3.3 Type II Diabetes
1.4 Global CIS Insulin Market by Regions
1.4.1 Global CIS Insulin Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) CIS Insulin Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) CIS Insulin Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CIS Insulin Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) CIS Insulin Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CIS Insulin Status and Prospect (2013-2023)
1.5 Global Market Size of CIS Insulin (2013-2023)
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 CIS Insulin Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novo Nordisk
2.2.1 Business Overview
2.2.2 CIS Insulin Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novo Nordisk CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.3 Takeda Pharmaceuticals
2.3.1 Business Overview
2.3.2 CIS Insulin Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Takeda Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi Aventis
2.4.1 Business Overview
2.4.2 CIS Insulin Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Aventis CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.5 Nanjing Xinbai Pharmaceutical
2.5.1 Business Overview
2.5.2 CIS Insulin Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Nanjing Xinbai Pharmaceutical CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.6 Oramed Pharmaceuticals
2.6.1 Business Overview
2.6.2 CIS Insulin Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Oramed Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 CIS Insulin Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.8 Boehringer Ingelheim
2.8.1 Business Overview
2.8.2 CIS Insulin Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Boehringer Ingelheim CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.9 Biocon
2.9.1 Business Overview
2.9.2 CIS Insulin Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Biocon CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
3 Global CIS Insulin Market Competition, by Players
3.1 Global CIS Insulin Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 CIS Insulin Players Market Share
3.2.2 Top 10 CIS Insulin Players Market Share
3.3 Market Competition Trend
4 Global CIS Insulin Market Size by Regions
4.1 Global CIS Insulin Revenue and Market Share by Regions
4.2 North America CIS Insulin Revenue and Growth Rate (2013-2018)
4.3 Europe CIS Insulin Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific CIS Insulin Revenue and Growth Rate (2013-2018)
4.5 South America CIS Insulin Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa CIS Insulin Revenue and Growth Rate (2013-2018)
5 North America CIS Insulin Revenue by Countries
5.1 North America CIS Insulin Revenue by Countries (2013-2018)
5.2 USA CIS Insulin Revenue and Growth Rate (2013-2018)
5.3 Canada CIS Insulin Revenue and Growth Rate (2013-2018)
5.4 Mexico CIS Insulin Revenue and Growth Rate (2013-2018)
6 Europe CIS Insulin Revenue by Countries
6.1 Europe CIS Insulin Revenue by Countries (2013-2018)
6.2 Germany CIS Insulin Revenue and Growth Rate (2013-2018)
6.3 UK CIS Insulin Revenue and Growth Rate (2013-2018)
6.4 France CIS Insulin Revenue and Growth Rate (2013-2018)
6.5 Russia CIS Insulin Revenue and Growth Rate (2013-2018)
6.6 Italy CIS Insulin Revenue and Growth Rate (2013-2018)
7 Asia-Pacific CIS Insulin Revenue by Countries
7.1 Asia-Pacific CIS Insulin Revenue by Countries (2013-2018)
7.2 China CIS Insulin Revenue and Growth Rate (2013-2018)
7.3 Japan CIS Insulin Revenue and Growth Rate (2013-2018)
7.4 Korea CIS Insulin Revenue and Growth Rate (2013-2018)
7.5 India CIS Insulin Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia CIS Insulin Revenue and Growth Rate (2013-2018)
8 South America CIS Insulin Revenue by Countries
8.1 South America CIS Insulin Revenue by Countries (2013-2018)
8.2 Brazil CIS Insulin Revenue and Growth Rate (2013-2018)
8.3 Argentina CIS Insulin Revenue and Growth Rate (2013-2018)
8.4 Colombia CIS Insulin Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue CIS Insulin by Countries
9.1 Middle East and Africa CIS Insulin Revenue by Countries (2013-2018)
9.2 Saudi Arabia CIS Insulin Revenue and Growth Rate (2013-2018)
9.3 UAE CIS Insulin Revenue and Growth Rate (2013-2018)
9.4 Egypt CIS Insulin Revenue and Growth Rate (2013-2018)
9.5 Nigeria CIS Insulin Revenue and Growth Rate (2013-2018)
9.6 South Africa CIS Insulin Revenue and Growth Rate (2013-2018)
10 Global CIS Insulin Market Segment by Type
10.1 Global CIS Insulin Revenue and Market Share by Type (2013-2018)
10.2 Global CIS Insulin Market Forecast by Type (2018-2023)
10.3 Long-Acting Analog Revenue Growth Rate (2013-2023)
10.4 Rapid Acting Analog Revenue Growth Rate (2013-2023)
10.5 Premixed Analog Revenue Growth Rate (2013-2023)
10.6 Intermediate Insulin Revenue Growth Rate (2013-2023)
10.7 Short Acting Insulin Revenue Growth Rate (2013-2023)
10.8 Premixed Insulin Revenue Growth Rate (2013-2023)
11 Global CIS Insulin Market Segment by Application
11.1 Global CIS Insulin Revenue Market Share by Application (2013-2018)
11.2 CIS Insulin Market Forecast by Application (2018-2023)
11.3 Type I and Other Diabetes Revenue Growth (2013-2018)
11.4 Type II Diabetes Revenue Growth (2013-2018)
12 Global CIS Insulin Market Size Forecast (2018-2023)
12.1 Global CIS Insulin Market Size Forecast (2018-2023)
12.2 Global CIS Insulin Market Forecast by Regions (2018-2023)
12.3 North America CIS Insulin Revenue Market Forecast (2018-2023)
12.4 Europe CIS Insulin Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific CIS Insulin Revenue Market Forecast (2018-2023)
12.6 South America CIS Insulin Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa CIS Insulin Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure CIS Insulin Picture
Table Product Specifications of CIS Insulin
Table Global CIS Insulin and Revenue (Million USD) Market Split by Product Type
Figure G
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
